Mostrar el registro sencillo del ítem

dc.contributor.author
Arrossi, Silvina  
dc.contributor.author
Paolino, Melisa Delia  
dc.contributor.author
Orellana, Liliana  
dc.contributor.author
Thouyaret, Laura  
dc.contributor.author
Kohler, Racquel  
dc.contributor.author
Viswanath, Kasisomayajula  
dc.date.available
2020-11-11T20:43:05Z  
dc.date.issued
2019-02  
dc.identifier.citation
Arrossi, Silvina; Paolino, Melisa Delia; Orellana, Liliana; Thouyaret, Laura; Kohler, Racquel; et al.; Mixed-methods approach to evaluate an mHealth intervention to increase adherence to triage of human papillomavirus-positive women who have performed self-collection (the ATICA study): Study protocol for a hybrid type i cluster randomized effectiveness-implementation trial; BioMed Central; Trials; 20; 1; 2-2019; 1-12  
dc.identifier.issn
1745-6215  
dc.identifier.uri
http://hdl.handle.net/11336/118224  
dc.description.abstract
Background: Cervical cancer is one of the leading causes of cancer death among women worldwide, with more than 85% of cases occurring in low- and middle-income countries. Human papillomavirus (HPV) screening allows for self-collection with the potential to increase coverage, but still requires triage to identify which HPV+ women need diagnostic and treatment procedures. However, achieving high levels of triage adherence can be challenging, especially among socially vulnerable women. This paper describes the ATICA protocol (Application of Communication and Information Technologies to Self-Collection, for its initials in Spanish), aimed at evaluating the implementation strategy and the effectiveness of a multi-component mobile health (mHealth) intervention to increase adherence to triage among women with HPV+ self-collected tests. Methods: We will use an effectiveness-implementation hybrid type I trial with a mixed-methods evaluation approach. A cluster randomized trial design including 200 community health workers (CHWs) will evaluate whether the mHealth intervention increases adherence to triage among HPV+ women who self-collected at home during a CHW visit within 120 days after a positive result. The intervention includes an initial mobile phone text message (SMS) alert and subsequent reminders sent to HPV+ women. For those who do not adhere to triage within 60 days of a positive HPV test, an email and SMS will be sent to the CHWs to promote contact with these women during home visits. We will use the Consolidated Framework for Implementation Research (CFIR) as an organizing and analytic framework to evaluate the implementation of the intervention while also drawing on Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM). We will conduct a self-administered, semi-structured survey of CHWs, semi-structured interviews with local health authorities, and a survey of HPV+ women. Combining both qualitative and quantitative data will provide rich insights into local implementation challenges and successes. Discussion: Findings from the implementation evaluation will be applicable to programs that use or are planning to incorporate HPV self-collection and/or mHealth interventions in different settings and countries. This innovative study will also serve as a model for using implementation science in the region.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
BioMed Central  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by/2.5/ar/  
dc.subject
COMMUNITY HEALTH WORKERS  
dc.subject
HPV  
dc.subject
IMPLEMENTATION  
dc.subject
MHEALTH  
dc.subject
SELF-COLLECTION  
dc.subject.classification
Otras Ciencias Médicas  
dc.subject.classification
Otras Ciencias Médicas  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Mixed-methods approach to evaluate an mHealth intervention to increase adherence to triage of human papillomavirus-positive women who have performed self-collection (the ATICA study): Study protocol for a hybrid type i cluster randomized effectiveness-implementation trial  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2020-11-11T12:31:42Z  
dc.journal.volume
20  
dc.journal.number
1  
dc.journal.pagination
1-12  
dc.journal.pais
Reino Unido  
dc.journal.ciudad
Londres  
dc.description.fil
Fil: Arrossi, Silvina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Centro de Estudio de Estado y Sociedad; Argentina  
dc.description.fil
Fil: Paolino, Melisa Delia. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Centro de Estudio de Estado y Sociedad; Argentina  
dc.description.fil
Fil: Orellana, Liliana. Deakin University; Australia  
dc.description.fil
Fil: Thouyaret, Laura. Instituto Nacional del Cáncer. 4 Programa Nacional de Prevención de Cáncer Cervicouterino; Argentina  
dc.description.fil
Fil: Kohler, Racquel. Harvard University. Harvard School of Public Health; Estados Unidos  
dc.description.fil
Fil: Viswanath, Kasisomayajula. Harvard University. Harvard School of Public Health; Estados Unidos  
dc.journal.title
Trials  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-019-3229-3  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/https://doi.org/10.1186/s13063-019-3229-3